Centers | ||
|
|
|
Edinburgh Drug Discovery | Weccome Centre for Anti-Infectives Research | EU-OPENSCREEN |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
WCAIR brings together the Drug Discovery Unit (DDU) , the Mode of Action group and the Parasitology research groups. With the daily interactions of these groups, parasitology and drug discovery can work together in synergy. This empowers us to create... Read more |
EU-OPENSCREEN is a multinational, not-for-profit initiative, which
integrates high-capacity screening platforms and chemistry groups across
Europe. The aim of this initiative is to support individual scientists
interested in chemical biology... |
Partnerships |
Events |
Jobs |
Sanofi and MIT Form New Partnership to Foster Industry - Academic CollaborationSanofi and MIT's Center for Biomedical Innovation has established a new partnership to foster basic and applied research and develop solutions to address unmet clinical needs. Sanofi will be providing funding to support specific research projects... View all IBD Therapeutics IncubatorIBD Therapeutics Incubator: Request for ProposalsThe Crohn’s & Colitis Foundation (Foundation) is dedicated to addressing the unmet needs of patients with inflammatory bowel diseases (IBD). The goal of this Request for Proposals (RFP) is to... View all GSK and Yale to partner on drug discovery developmentGlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies. View all |
No EVENTS for listing |
No Job Posts |
